Molecular Studies of HIV-1 Drug Resistance in Lagos, Nigeria - Salu, Olumuyiwa Babalola;Omilabu, Sunday Aremu;Oyibo, Wellington A.
42,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in über 4 Wochen
  • Broschiertes Buch

The use of combinations of antiretroviral drugs has proven remarkably effective in controlling the progression of human immunodeficiency virus (HIV) disease and prolonging survival. However, transmission of drug-resistant HIV-1 has been observed in countries where antiretroviral treatment is available and it can jeopardize the success of antiretroviral therapy (ART) programme. Thus, the study aimed to determine the transmission of drug resistant strains and to characterize the Resistance mutations in treatment naïve HIV-1 infected subjects in Lagos, Nigeria.

Andere Kunden interessierten sich auch für
Produktbeschreibung
The use of combinations of antiretroviral drugs has proven remarkably effective in controlling the progression of human immunodeficiency virus (HIV) disease and prolonging survival. However, transmission of drug-resistant HIV-1 has been observed in countries where antiretroviral treatment is available and it can jeopardize the success of antiretroviral therapy (ART) programme. Thus, the study aimed to determine the transmission of drug resistant strains and to characterize the Resistance mutations in treatment naïve HIV-1 infected subjects in Lagos, Nigeria.
Autorenporträt
Dr. Salu, Olumuyiwa Babalola has an M.Sc and Ph.D in Medical Microbiology (Virology). He is currently a lecturer at the Department of Medical Microbiology and Parasitology and laboratory coordinator of the Virology Research Unit Laboratory, Central Research Laboratory (CMUL) with over 25 published articles in peer-reviewed journal.